Top compounds associated with response to MYO1C


Feature Type Standardized
Nominal ANOVA
mRNA Panobinostat CCLE pan-cancer AAC -0.21 7e-05
mRNA 17-AAG CCLE pan-cancer AAC 0.18 0.004
mRNA PLX4720 CCLE pan-cancer AAC 0.12 0.03
mRNA Crizotinib CCLE pan-cancer AAC -0.12 0.04
mRNA L-685458 CCLE pan-cancer AAC -0.12 0.04
mRNA Nilotinib CCLE pan-cancer AAC -0.11 0.09
mRNA Topotecan CCLE pan-cancer AAC -0.082 0.1
mRNA Nutlin-3 CCLE pan-cancer AAC 0.086 0.2
mRNA TKI258 CCLE pan-cancer AAC -0.063 0.3
mRNA Irinotecan CCLE pan-cancer AAC -0.063 0.4
Download CSV